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Abstract 
Growth Arrest and DNA-damage-inducible, alpha 
(GADD45α) is a member of the GADD family 
proteins that also include GADD45β and 
GADD45γ.  
The highly conserved GADD45 proteins are small 
(18 kDa) and primarily localized in the nucleus. 
The GADD45 proteins acting as sensors of 
environmental and physiological stress interact with 
and/or modulate the activities of partner proteins 
involved in cell cycle, cell survival, apoptosis, 
maintenance of genomic stability and DNA repair. 
GADD45 proteins also act as sensors of oncogenic 
stress in the initiation of tumors and in tumor 
responses to different therapeutics.  
The expression of GADD45α in response to DNA 
damage is mediated by p53-dependent and p53-
independent mechanisms, the latter which involves 
Wilms tumor 1 (WT1) protein. GADD45α 
subsequently inhibits G2/M transition of cell cycle 
and induces apoptosis. GADD45α also has a role in 
DNA-demethylation to promote genome stability. 
In many malignancies, GADD45α levels are down-
regulated, likely allowing tumor cells to escape  
 
from senescence and apoptosis.  
Novel approaches are therefore being developed to 
regulate GADD45α levels to combat malignancies. 
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Other names: DDIT1, GADD45 
HGNC (Hugo): GADD45A 
Location: 1p31.3 
DNA/RNA 
Description 
The human GADD45α is localized on chromosome 
1 and comprises four exons (NCBI, 2014). 
Transcription 
Depending on the splicing of the GADD45α pre-
mRNA, there are three mRNA variants. 
Pseudogene 
Homologous sequence on chromosome 12q may be 
a retro-pseudogene (Papathanasiou et al., 1991). 
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Human GADD45α located on chromosome 1 is on the forward strand. It consists of four exons represented as boxes and introns 
shown as lines. Darker grey boxes indicate the open reading frame (ORF) of 498 base pairs (bp). The first methionine (ATG) and 
the stop codon (TGA) of ORF are marked. The length of each exon and intron is shown in base pairs. 
 
Protein 
Note 
Based on mRNA sequences, it is predicted that 
there are three isoforms of GADD45α protein 
(NCBI, 2014). While the isoform 1 utilizes 498 bp 
ORF encoding 165 amino acids (aa)-long protein 
(protein ID: NP_001915.1), the absence of the 
second in-frame exon in the isoform 2 results in a 
396 bp ORF giving rise to a 131 aa-long protein 
(protein ID: NP_001186670.1). In the isoform 3, 
the second and third exons partially exist forming a 
183 bp mRNA that encodes a 60 aa-long protein 
(protein ID: NP_001186671.1). 
Description 
GADD45α protein is a member of the GADD 
family that includes GADD45β and GADD45γ. 
Forming a homodimer as well as heterodimers with 
other family members, GADD45α is involved in the 
maintenance of genomic integrity, growth arrest 
and apoptosis (Rosemary Siafakas and Richardson, 
2009; Sytnikova et al., 2011) through interactions 
with various proteins including Cdc2 protein 
kinase, Waf1/Cip1 ID: 139> protein, core histone 
proteins, proliferating cell nuclear antigen (PCNA) 
and MTK/MEKK4 (Zerbini and Libermann, 2005; 
Zhan, 2005; Rosemary Siafakas and Richardson, 
2009; Johnson et al., 2013). GADD45α also acts as 
an RNA binding protein (Sytnikova et al., 2011). 
Ubiquitination appears to be involved in the 
turnover of GADD45α (Leung et al., 2001). 
Expression 
Protein levels of GADD45α varies during the cell 
cycle, the highest being in G1 phase and the lowest 
in S phase (Zhan, 2005; Rosemary Siafakas and 
Richardson, 2009). The expression of GADD45α is 
regulated by p53-dependent and p53-independent 
mechanisms. The p53-dependent pathway involves 
the direct binding of p53 to a cognate response 
element located on the third intron of GADD45α. 
Whereas, in the p53-independent signaling route, 
p53 modulates GADD45α expression by interacting 
with WT1, a transcription factor and a tumor 
suppressor, bound on GC-rich motifs of the 
GADD45α promoter (Zhan, 2005; Johnson et al., 
2013). Rapid and transient expression of GADD45α 
can be induced by DNA damaging agents including 
UV (p53-independent), ionizing radiation (p53-
dependent), methylmethane sulfonate (MMS), 
nitrogen mustard, melphalan, hydrogen peroxide 
and hypoxia as well as by the withdrawal of growth 
factors (Hollander and Fornace, 2002; Zhan, 2005; 
Rosemary Siafakas and Richardson, 2009). 
GADD45α expression is also activated by breast 
cancer 1, early onset, (BRCA1) in various cell lines 
(Harkin et al., 1999). 
Localisation 
GADD45α, as other members of GADD family 
proteins, is predominantly localized in the nucleus 
(Zhan, 2005; Rosemary Siafakas and Richardson, 
2009). In glioblastoma and breast tumors, 
GADD45α is also observed to localize in the 
cytoplasm (Reddy et al., 2008; Tront et al., 2013). 
Function 
The maintenance of genome integrity is essential to 
prevent the development of cancer, which is 
associated with genomic instability. GADD45α 
plays an important role in maintaining genomic 
integrity by promoting nucleotide-excision repair 
(NER), cell cycle arrest and apoptosis (Hollander 
and Fornace, 2002; Barreto et al., 2007; Sytnikova 
et al., 2011).  
GADD45α mediates NER by binding to repair 
endonuclease xeroderma pigmentosum G (XPG) 
protein (Hollander and Fornace, 2002; Barreto et 
al., 2007; Sytnikova et al., 2011). While the 
disruption of Cdc2/Cyclin B1 interactions by 
GADD45α is critical for the blockage of G2/M 
transition (Zhan et al., 1999; Rosemary Siafakas 
and Richardson, 2009), the activation of c-Jun N-
terminal kinase (JNK) as a result of the interaction 
of GADD45α with mitogen-activated protein three 
kinase (MTK1) induces apoptosis (Zerbini and 
Libermann, 2005). GADD45α is also reported to 
repress cell migration and invasion by suppressing 
β-catenin signaling through stress-mediated p38 
mitogen activated protein kinase (MAPK) pathway 
(Hildesheim et al., 2004). 
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Homology 
The human GADD45α shows 90% aa identity to 
GADD45α of other species including rhesus 
monkey, domestic cat, hamster, mouse and rat 
(Rosemary Siafakas and Richardson, 2009).  
In addition, there is a nearly 50% aa identity among 
GADD45α and other GADD45 proteins (Rosemary 
Siafakas and Richardson, 2009).  
The RNA-binding domain of GADD45α displays 
high aa homology to many RNA binding proteins 
that includes ribosomal proteins L7a, S12 and L30e 
(Sytnikova et al., 2011; Tian and Locker, 2013). 
Implicated in 
Colorectal carcinoma 
Note 
In primary colorectal carcinoma tissue samples 
grouped according to tumor staging (group 1: 
restricted to gut; group 2: restricted to gut but signs 
of malignancy on lymph nodes are present; group 3: 
in addition to group 2 characteristics, metastasis to 
distant tissue is present), it was observed that 
GADD45α expression decreases as staging 
increases.  
Whereas, GADD45α expression in close proximity 
or distant tissues remains unchanged (Štorcelová et 
al., 2013). 
Breast cancer 
Note 
Intracellular level of GADD45α assessed by 
immunocytochemistry is reported to positively 
correlate with the presence of estrogen and 
progesterone receptors in primary breast cancer 
samples (Tront et al., 2013).  
It appears that GADD45α levels are higher in 
Luminal A (ER+, PR+, HER2-) and Luminal B 
(ER+, PR+, HER2+) subgroups of tumors than 
HER2+ (HER2+, ER-,PR-) and Triple Negative 
(ER-, PR-, HER2-) subgroups (Tront et al., 2013). 
Gastric cardia adenocarcinoma 
Note 
Relative mRNA expression evaluated by qPCR of 
gastric cardia adenocarcinoma (GCA) samples 
suggests that the expression of GADD45α is 
repressed compared to that of neighboring normal 
tissue samples. Based on TNM staging, GADD45α 
mRNA levels were found to be higher in Stage I 
and Stage II patient samples than Stage III and 
Stage IV patient samples. Higher degree of 
methylation of the GADD45α gene promoter 
appears to be one reason for the decreased 
expression of GADD45α in GCA. There were no 
other correlation between GADD45α mRNA levels 
and clinicopathological characteristics (Guo et al., 
2013). 
Glioblastoma 
Note 
In diffuse-infiltrating astrocytomas, the expression 
of GADD45α assessed by qPCR shows variations 
depending on tumor grading. It appears that 
GADD45α is expressed at higher levels in 
glioblastoma (GBM; WHO grade IV) compared to 
astrocytoma (DA; WHO grade II) or to anaplastic 
astrocytoma (AP; WHO grade III) (Reddy et al., 
2008). 
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